The study by Milanski et al. revealed that inhibition of the function of hypothalamic TLR4 by anti-TLR4 antibody reversed obesity-related liver diseases by improved insulin signal transduction in the liver11, which is in line with our findings. This evidence concerns the gene INS and liver disorder.